Maryland State Retirement & Pension System’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-7,707
Closed -$639K 1517
2022
Q1
$639K Buy
+7,707
New +$568K 0.02% 875
2021
Q4
Sell
-7,707
Closed -$893K 1521
2021
Q3
$893K Buy
+7,707
New +$1.17M 0.03% 688
2021
Q2
Sell
-7,707
Closed -$1.02M 976
2021
Q1
$1.02M Buy
7,707
+6,077
+373% +$961K 0.04% 477
2020
Q4
$262K Buy
+1,630
New +$223K 0.05% 385

Other funds holding NVCR

Maryland State Retirement & Pension System's NVCR Position: Q2 2022 in Review

Maryland State Retirement & Pension System sold out of NovoCure (NVCR) in Q2 2022, closing a stake of 7,707 shares — an estimated $639K sold.

Maryland State Retirement & Pension System first reported a position in NVCR in Q4 2020 and held it in 4 quarters. The position peaked at $1.02M in Q1 2021. 316 funds tracked by Wall St. Rank hold NVCR as of Q2 2022.

  • Maryland State Retirement & Pension System reported no remaining NovoCure position as of Q2 2022 after selling out during the quarter.
  • Maryland State Retirement & Pension System sold 7,707 NovoCure shares in Q2 2022, an estimated $639K.
  • Maryland State Retirement & Pension System first reported a position in NovoCure in Q4 2020 and held it in 4 quarters.
  • Maryland State Retirement & Pension System's NovoCure position peaked at $1.02M in Q1 2021.
  • 316 funds tracked by Wall St. Rank held NovoCure as of Q2 2022.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2022, filed 1 Aug 2022.